CRP and cardiovascular disorder: Furthermore, the HS-CRP levels were considerably close and showed no statistical differences, suggesting that no inflammation or cardiovascular disorders or malfunctions occurred in mice that received treatments either with TPZ, GNPs, or GNPs–TPZ (Table 1).